Icahn School of Medicine at Mount Sinai

 

Icahn School of Medicine at Mount Sinai
S

Leveraging Dysregulated Signaling Networks for Therapeutic Benefit in Myeloid Malignancies

By Icahn School of Medicine at Mount Sinai FEATURING Stephen Oh
By Icahn School of Medicine at Mount Sinai FEATURING Stephen Oh
19 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login
Myeloid Malignancy Workshop
06:03

Strategies to Overcome Immune Dysregulation in MPNs

Icahn School of Medicine at Mount Sinai

C. Cimen Bozkus

30 views
26:23

Boosting MHC:TCR Interactions in AML

Icahn School of Medicine at Mount Sinai

I. Aifantis

27 views
20:26

Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias

Icahn School of Medicine at Mount Sinai

O. Abdel-Wahab

57 views
03:33

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associ…

Icahn School of Medicine at Mount Sinai

K. Chin

21 views
36:18

Stem Cell Pathways, Aging, and Cancer Evolution in MPN

Icahn School of Medicine at Mount Sinai

C. Jamieson

19 views
28:30

Leveraging Dysregulated Signaling Networks for Therapeutic Benefit i…

Icahn School of Medicine at Mount Sinai

S. Oh

19 views
26:45

Targeting Mutant Calreticulin in MPN

Icahn School of Medicine at Mount Sinai

A. Mullally

45 views
18:59

BMT for MDS: Updates and Tricky Case Discussion

Icahn School of Medicine at Mount Sinai

A. DeZern

170 views
27:08

Emerging Landscape of Treating Anemia in LR-MDS

Icahn School of Medicine at Mount Sinai

R. Komrokji

85 views
29:54

State-of-the-Art Management of Systemic Mastocytosis

Icahn School of Medicine at Mount Sinai

D. DeAngelo

81 views
12:06

MDS: Prospects for Individualized Therapy With Targeted Therapies Po…

Icahn School of Medicine at Mount Sinai

L. Silverman

67 views
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

417 views
34:57

BPDCN: Current and Future Directions

Icahn School of Medicine at Mount Sinai

N. Pemmaraju

473 views